US Life Sciences Company Thermo Fisher Opens Bio Technology Experience Center in Songdo, Incheon

Equipped with over 100 process equipment and laboratories including cultivation and purification processes

Thermo Fisher Bio Process Design Center (BDC) opened in Songdo, Incheon [Photo provided by Incheon Free Economic Zone Authority]

[Asia Economy Reporter Park Hyesook] A Thermo Fisher Biopharmaceutical Process Support Center, where visitors can experience cutting-edge process solutions necessary for producing various types of vaccines including mRNA vaccines (vaccines utilizing messenger RNA containing the genetic information of viruses), has been established in Songdo International City, Incheon Free Economic Zone.

According to the Incheon Free Economic Zone Authority on the 1st, the American life sciences company Thermo Fisher Scientific opened the state-of-the-art biopharmaceutical technology experience center called the 'Bio Process Design Center' (BDC) on the same day.

The BDC is equipped with over 100 process devices used in biopharmaceutical research and production such as culture, purification, and quality analysis, as well as a 760㎡ laboratory and educational spaces.

To cultivate experts in biopharmaceutical process design, the center plans to provide education on the latest trends in biopharmaceutical production and processes both online and offline, along with various customized seminars and conferences for customers.

Additionally, at the BDC, biopharmaceutical companies can experience process solutions for producing various types of vaccines including mRNA vaccines, and can experience all process solutions in one place, from isolating stem cells obtained from patients' blood to culturing and purification.

Thermo Fisher, headquartered in Waltham, Massachusetts, USA, supplies advanced technology services related to approximately 800,000 life science products worldwide, including Korea. As of last year, its sales reached $30 billion (approximately 33 trillion KRW), and it employs about 70,000 people.

Recently, it signed a vaccine production contract with the American pharmaceutical company Moderna, leading global vaccine supply efforts, and is expanding its scope beyond bio process solutions to contract manufacturing organization (CMO), solidifying its position as a life sciences company.

Seok Sujin, CEO of Thermo Fisher Scientific Korea, stated, "We will make the BDC a leading bio process experience platform in Korea and play a key role in advancing Korea's bio industry and enhancing national competitiveness."

This content was produced with the assistance of AI translation services.